Patel Gautam
Amneal Pharmaceuticals, Inc. · Director
Patel Gautam is listed in filings as Director at Amneal Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through May 8, 2026, including sale activity. Recent filings connect the profile to Amneal Pharmaceuticals, Inc. (AMRX) and Spectrum Brands Holdings Inc (SPB). The current snapshot covers public activity from Nov 20, 2024 to May 8, 2026. Reported amounts are shown as $761.1K to $39.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $453k56.4k shares | SellJun 10, 2025 | $8.02 | $12.78 | |
| $39k4.9k shares | SellMay 5, 2025 | $8.00 | $12.78 | |
| $30k3.8k shares | SellMay 2, 2025 | $8.00 | $12.78 | |
| $664k80k shares | SellApr 1, 2025 | $8.30 | $12.78 | |
| $712k80k shares | SellMar 3, 2025 | $8.90 | $12.78 | |
| $651k80k shares | SellFeb 3, 2025 | $8.14 | $12.78 | |
| $501k62.6k shares | SellJan 8, 2025 | $8.01 | $12.78 | |
| $139k17.4k shares | SellJan 2, 2025 | $8.01 | $12.78 |